Psychedelic Therapy and Trauma A New Frontier in Mental Health with Dr. Will Van Derveer | E212

In this pivotal episode of The Empowering Neurologist Podcast, host Dr. David Perlmutter engages in a profound conversation with Dr. Will Van Derveer, a psychiatrist and pioneer in psychedelic-assisted therapy. Dr. Van Derveer shares his personal journey from conventional psychiatry to integrating indigenous shamanic practices and clinical research, emphasizing that psychedelic therapy is not a quick fix but a transformative, multi-stage process requiring rigorous preparation, skilled facilitation, and deep integration. He details the groundbreaking results of MDMA-assisted therapy for PTSD—where two-thirds of participants no longer met diagnostic criteria after treatment—and discusses the current regulatory landscape, including FDA delays, state-level legalization in Colorado and Oregon, and the critical need for federal standardization. The episode underscores that healing lies not in the medicine alone, but in the therapeutic relationship, trauma-informed care, and a holistic, integrative approach that addresses metabolic, inflammatory, and lifestyle factors. Dr. Van Derveer warns against unregulated psychedelic tourism, citing risks like cardiac toxicity with ibogaine and psychological trauma from poorly supervised ceremonies, advocating instead for trained professionals and ethical frameworks. He also explores the potential of microdosing, GLP-1 medications, and the role of genetics in mental health, ultimately positioning psychedelic therapy as a catalyst for lasting change when embedded within a comprehensive model of wellness. Key takeaways include: (1) Psychedelic therapy is most effective when paired with skilled psychotherapy and integration, not used as a standalone intervention; (2) The healing process is not about the psychedelic experience itself, but about creating safe, structured conditions for insight and lasting change; (3) Trauma is stored in the nervous system, requiring modalities that go beyond talk therapy; (4) Rigorous vetting of providers and settings is essential—especially for high-risk substances like ibogaine; (5) Integration is not optional; it’s the bridge between insight and sustainable transformation; (6) Lifestyle medicine, including diet, sleep, and metabolic health, must be part of the healing journey; (7) The pharmaceutical model’s focus on symptom suppression is outdated; true healing requires addressing root causes; (8) Tools like GLP-1s and microdosing may offer benefits but should not replace foundational lifestyle changes. The episode concludes with a powerful call to move beyond hype and embrace psychedelic therapy as a responsible, science-grounded frontier in mental health.